GT BIOPHARMA, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2011
Total Assets: $129.0K
Liabilities Breakdown FY2011
Total Liabilities: $5.2M
Asset Breakdown
Total Assets: $129.0K
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $92.0K | 71.3% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $12.0K | 9.3% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $25.0K | 19.4% |
Liabilities Breakdown
Total Liabilities: $5.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $806.0K | 15.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $4.4M | 84.6% |